These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
349 related items for PubMed ID: 20924086
1. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Suzuki H, Yamamoto E, Nojima M, Kai M, Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, Takamaru H, Niinuma T, Maruyama R, Yamamoto H, Tokino T, Imai K, Toyota M, Shinomura Y. Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086 [Abstract] [Full Text] [Related]
2. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Cancer Res; 2008 Jun 01; 68(11):4123-32. PubMed ID: 18519671 [Abstract] [Full Text] [Related]
3. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. Cancer Res; 2007 Sep 15; 67(18):8433-8. PubMed ID: 17823410 [Abstract] [Full Text] [Related]
4. [Developing technologies for epigenomic analysis and clinical application of molecular diagnosis]. Yamamoto E, Suzuki H, Maruyama R, Shinomura Y. Rinsho Byori; 2012 Jul 15; 60(7):637-43. PubMed ID: 22973723 [Abstract] [Full Text] [Related]
5. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. Carcinogenesis; 2010 May 15; 31(5):766-76. PubMed ID: 19843643 [Abstract] [Full Text] [Related]
8. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Cancer Res; 2008 Apr 01; 68(7):2094-105. PubMed ID: 18381414 [Abstract] [Full Text] [Related]
10. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Watanabe K, Emoto N, Hamano E, Sunohara M, Kawakami M, Kage H, Kitano K, Nakajima J, Goto A, Fukayama M, Nagase T, Yatomi Y, Ohishi N, Takai D. Int J Cancer; 2012 Jun 01; 130(11):2580-90. PubMed ID: 21702040 [Abstract] [Full Text] [Related]
11. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Ando T, Yoshida T, Enomoto S, Asada K, Tatematsu M, Ichinose M, Sugiyama T, Ushijima T. Int J Cancer; 2009 May 15; 124(10):2367-74. PubMed ID: 19165869 [Abstract] [Full Text] [Related]
12. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J. Oncogene; 2005 Dec 01; 24(54):8051-60. PubMed ID: 16103878 [Abstract] [Full Text] [Related]
13. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai CH, Kao HW, Fang WL, Huang KH, Chan WC, Lin WC. Int J Cancer; 2011 Dec 01; 129(11):2600-10. PubMed ID: 21960261 [Abstract] [Full Text] [Related]
14. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Pigazzi M, Manara E, Baron E, Basso G. Cancer Res; 2009 Mar 15; 69(6):2471-8. PubMed ID: 19258499 [Abstract] [Full Text] [Related]
15. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180 [Abstract] [Full Text] [Related]
16. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T. Cancer Genet Cytogenet; 2010 Feb 15; 197(1):16-24. PubMed ID: 20113832 [Abstract] [Full Text] [Related]
17. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT, Zhang FB, Fan YC, Shu XS, Wong AH, Zhou W, Shi QL, Tang HM, Fu L, Guan XY, Rha SY, Tao Q, He C. Oncogene; 2009 Jul 02; 28(26):2466-75. PubMed ID: 19448674 [Abstract] [Full Text] [Related]
18. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis. Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J. Oncogene; 2006 Oct 19; 25(49):6554-62. PubMed ID: 16715143 [Abstract] [Full Text] [Related]
19. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia. Gao XN, Lin J, Li YH, Gao L, Wang XR, Wang W, Kang HY, Yan GT, Wang LL, Yu L. Oncogene; 2011 Aug 04; 30(31):3416-28. PubMed ID: 21399664 [Abstract] [Full Text] [Related]
20. Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W. Cancer; 2006 Mar 15; 106(6):1250-9. PubMed ID: 16475210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]